Pharmacokinetics and cyclooxygenase inhibition of itazigrel in normal volunteers after single oral dosesPOE-HIRR HSYU; KOETS, M. D; LUDERER, J. R et al.Journal of pharmaceutical sciences. 1994, Vol 83, Num 12, pp 1747-1750, issn 0022-3549Article

Rapid extraction of arachidonic acid metabolites utilizing octadecyl reversed-phase columnsLUDERER, J. R; RILEY, D. L; DEMERS, L. M et al.Journal of chromatography. 1983, Vol 273, Num 2, pp 402-409, issn 0021-9673Article

Age and ceftriaxone kineticsLUDERER, J. R; PATEL, I. H; DURKIN, J et al.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 1, pp 19-25, issn 0009-9236Article

The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteersWOLF, D. L; FERRY, J; HEARRON, A. E et al.European journal of clinical pharmacology. 1993, Vol 44, Num 1, pp 27-33, issn 0031-6970Article

Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutterKOWEY, P. R; VANDERLUGT, J. T; LUDERER, J. R et al.The American journal of cardiology. 1996, Vol 78, Num 8A, pp 46-52, issn 0002-9149Conference Paper

Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest painARNOLD, J. M. O; KOWEY, P. R; WOLF, D. L et al.International journal of cardiology. 1994, Vol 44, Num 3, pp 203-215, issn 0167-5273Article

Dazoxiben, a thromboxane synthetase inhibitor, in Raynauds phenomenonLUDERER, J. R; NICHOLAS, G. G; NEUMYER, M. M et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 1, pp 105-115, issn 0009-9236Article